Plus   Neg

Amgen: ABP 798 Shows Clinical Equivalence To Rituxan In Clinical Study

Amgen (AMGN) and Allergan plc (AGN) said a clinical study demonstrated clinical equivalence of ABP 798 to Rituxan in patients with CD20-positive B-cell non-Hodgkin's lymphoma. In the study, the overall response rate by week 28 was within the prespecified margin for ABP 798.

Safety and immunogenicity of ABP 798, a biosimilar candidate, were comparable to Rituxan. The comparative clinical study was the second of two studies to support regulatory submissions for ABP 798.

In 2011, Amgen and Allergan plc formed a collaboration to develop and commercialize oncology antibody biosimilar medicines.

For comments and feedback contact: editorial@rttnews.com

Business News

Editors Pick
Apotex Corp. recalled all lots of type 2 diabetes medication Metformin hydrochloride in the form of oral film-coated tablets for the potential presence of nitrosamine impurity, N-Nitrosodimethylamine (NDMA), above levels of the Acceptable Daily Intake Limit (ADI), the U.S. Food and Drug Administration or FDA said in a statement. Groupe Renault plans to cut about 14,600 jobs across the world and lower its production capacity. The plan includes almost 4,600 jobs reduction in France, through voluntary retirement and retraining. Amazon said it will convert 125,000 of the 175,000 temporary workers it hired in March amid the coronavirus pandemic, to permanent full-time employees in June. The e-commerce giant had hired the temporary employees in March to meet strong consumer demand amid the lockdown. The job openings were in Amazon's fulfillment centers and its delivery network.
Follow RTT